CURRENT PROJECTS
OP TAK Fixed Dose (CZ.01.01.01/01/25_067/0009656)
Development and clinical validation of new oral fixed-dose combinations of active substances for the treatment of cardiometabolic diseases
Principal investigator: PharmDr. Josef Mašek, Ph.D.
GAČR 26-20880S
From Molecular Design to Clinical Application: Personalized 3D+ Polysaccharide Wound Dressings Integrating Antiseptics and Natural Compounds
Principal investigator: PharmDr. Josef Mašek, Ph.D.
NAZV QL26010426 (DewormRESBIO)
Environmental Impact of Antiparasitic Residues from Grazing Livestock on Pasture Biodiversity
Principal investigator: doc. MVDr. Adam Novobilský, Ph.D.
AZV NW25-08-00401
Formulation of atropine into modern noninvasive delivery systems
Principal investigator: PharmDr. Josef Mašek, Ph.D.
AZV NW25-03-00462
Preclinical research on the therapeutic potential of new platinum complexes in multiple myeloma
Principal investigator: Mgr. Renata Héžová, Ph.D.
AZV NW25J-01-00013
Identification of patients with sleep-disordered breathing with increased cardiovascular risk in chronic systemic inflammation
Principal investigator: Mgr. Nicol Straková, Ph.D.
VRI Returns (EH24_037/0013867)
Support for Returning after a Career Break and Sustainable Career Development at VRI: VRI Returns
Principal investigator: Mgr. Martina Fojtíková, Ph.D.
OP TAK Kardio (CZ.01.01.01/01/24_063/0006627)
Development and Optimization of an Injectable Prolonged-Release Drug Formulation for Modern Cardiac Therapy
Principal investigator: PharmDr. Josef Mašek, Ph.D.
NAZV QL24010430 (rFSH)
Production of recombinant bovine follicle stimulating hormone with controlled release from hydrogels for assisted reproductive techniques in cattle
Principal investigator: doc. MVDr. Svatopluk Čech, Ph.D. (for the department: PharmDr. Josef Mašek, Ph.D.)
NAZV QL24010306 (GoSheePar)
Sustainable parasite control in small ruminants corresponding to the One Health concept
Principal investigator: doc. MVDr. Adam Novobilský, Ph.D.
OP TAK Canatop (CZ.01.01.01/01/22_002/0001061)
Innovative products based on active substances from hemp with high bioavailability for topical application with a local effect
Principal investigator: PharmDr. Josef Mašek, Ph.D.
TAČR NaCeBiVet (TN02000017)
National Centre for Biotechnology in Veterinary Medicine
Dyntec: PharmDr. Josef Mašek, Ph.D.
Pharmagal: doc. MVDr. Adam Novobilský, Ph.D.
